Sign in
WithdrawnPhase 2

Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)

Key facts

Who runs it
University of California, Los Angeles
Where
Los Angeles, United StatesSee the site
Trial code
Status
Withdrawn
Phase
Phase 2
Started
Sept 2020
Ended
Jun 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Sodium Lactate
  • Placebo
Record updated
15 November 2021
Why it stopped
The manufacturer of sodium lactate has stopped making the medication

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Adult patients seen in the Medical Center Emergency Department
  • Adult patients transferred to the Neurocritical Intensive Care Unit with a physician's diagnosis of brain injury
  • GCS 3-12

Who cannot take part

  • Previous severe diminished mental capacity
  • History of diabetes mellitus
  • History of hemodynamic instability
  • Known terminal illness which alters brain functioning
  • Diagnosed AIDS progressed to AIDS dementia
  • Known history of chronic severe neurological disturbance
  • Active neurologic condition such as stroke, recent TBI
  • metabolic disorder
  • Pregnancy at time of injury
  • Severe retardation
  • No command of either English or Spanish
  • Arrest for a felony
  • preexisting hyperlactatemia
  • instability precluding experimental intervention

Where in United States

  • David Geffen School of Medicine at UCLALos Angeles, United States

About the trial

What the trial wants to find out

Metabolic crisis is a state of energy insufficiency due to impaired mitochondrial function as indicated by cerebral microdialysis lactate/pyruvate ratio (LPR). We have performed preliminary mechanistic analysis of alternative fuels in humans and have demonstrated proof of concept that exogenous fuels alter brain metabolism. We will conduct a multicenter, adaptive design-based, proof of concept phase 2 safety study of candidate supplemental fuels in patients with severe traumatic brain injury to determine safety and efficacy.

The 2 groups in the trial

  • ELI ArmTreatment being tested

    Infusion of exogenous sodium lactate as supplemental fuel within 48 hours of TBI

    Treatment: Sodium Lactate

  • PlaceboPlacebo, for comparison

    Placebo infusion of normal saline in Part 2 RCT

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
15 November 2021